The researchers analyzed information from 1,237 IBD patients. Providers performed 4,327 colonoscopies on the study’s patients between Jan. 1, 2000 and Jan. 1, 2014.
Here are five points:
1. The researchers found colon cancer developed in 1.3 percent of patients whose interval between colonoscopies was 22 months.
2. The researchers detected only 17 cancers during follow-up evaluation.
3. Based on the study’s findings, researchers concluded patients not deemed high risk can go nearly five years in between colonoscopy procedures.
4. Investigators concluded IBD patients undergoing regular colonoscopies have a lower interval colorectal cancer occurrence.
5. Currently, the British Society of Gastroenterology and the European Crohn’s and Colitis Organization recommend IBD patients undergo a colonoscopy once every five years.
More articles on GI & endoscopy:
AGA, Takeda Pharmaceuticals U.S.A. to fund IBD research: 3 things to know
Revenue per GI/endoscopy case in ASCs: 18 statistics
UNC researchers develop diagnostic criteria for GI disorders — 5 points
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.